scispace - formally typeset
K

Kuljit Singh

Researcher at Rajendra Memorial Research Institute of Medical Sciences

Publications -  10
Citations -  178

Kuljit Singh is an academic researcher from Rajendra Memorial Research Institute of Medical Sciences. The author has contributed to research in topics: Leishmania donovani & Trypanothione. The author has an hindex of 8, co-authored 10 publications receiving 131 citations.

Papers
More filters
Journal ArticleDOI

Current Therapeutics, Their Problems and Thiol Metabolism as Potential Drug Targets in Leishmaniasis.

TL;DR: The aspects of chemotherapy of leishmaniasis by synthetic and natural drugs, their mechanism of action, pharmacokinetics and involvement in the development of drug resistance are reviewed.
Journal ArticleDOI

Deciphering the interplay between cysteine synthase and thiol cascade proteins in modulating Amphotericin B resistance and survival of Leishmania donovani under oxidative stress.

TL;DR: It is reported that over-expression of LdCS in Amphotericin B (Amp B) sensitive strain (S1-OE) modulates resistance towards oxidative stress and drug pressure, and reveals a novel crosstalk between Ld CS and thiol metabolic pathway proteins and demonstrates the crucial role in drug resistance and redox homeostasis of Leishmania.
Journal ArticleDOI

Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase.

TL;DR: It is demonstrated at the translational level that Ld-cTXN protein is upregulated in Amp B resistant isolates accompanied by enhanced peroxidase activity, as compared to sensitive strains.
Journal ArticleDOI

Proteomic approaches unravel the intricacy of secreted proteins of Leishmania: An updated review.

TL;DR: Various secretion mechanisms used by Leishmania parasites to export the proteins into the extracellular space are summarized; followed by the role of proteomics in exoproteome analysis along with special emphasis on various applications to study the exoproteinome, which might provide potential targets for drug design or novel antigens for vaccine development.